{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:48Z","timestamp":1786984368617,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.annder.2018.07.029","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T09:14:57Z","timestamp":1540286097000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recommandations diagnostiques et th\u00e9rapeutiques pour les maladies sexuellement transmissibles\u00a0: herp\u00e8s g\u00e9nital au cours de la grossesse"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3679-6613","authenticated-orcid":false,"given":"B.","family":"Milpied","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Janier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Spenatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Caumes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sentilhes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-V.","family":"Senat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2018.07.029_bib0150","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM198304213081602","article-title":"Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects","volume":"308","author":"Bryson","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2018.07.029_bib0155","first-page":"33","article-title":"Efficacy of oral treatment with acyclovir and co-trimoxazole in first episode genital herpes","volume":"62","author":"Kinghorn","year":"1986","journal-title":"Genitourin Med"},{"key":"10.1016\/j.annder.2018.07.029_bib0160","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jama.1984.03350090023017","article-title":"Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection","volume":"252","author":"Mertz","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.annder.2018.07.029_bib0165","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(82)90658-4","article-title":"Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes","volume":"2","author":"Nilsen","year":"1982","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.annder.2018.07.029_bib0290","first-page":"CD010684","article-title":"Interventions for men and women with their first episode of genital herpes","volume":"30","author":"Heslop","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.annder.2018.07.029_bib0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00007435-199709000-00007","article-title":"Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Groooup","volume":"24","author":"Fife","year":"1997","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.annder.2018.07.029_bib0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/12.suppl_B.29","article-title":"Pharmacokinetics of acyclovir after intravenous and oral administration","volume":"12","author":"de Miranda","year":"1983","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.annder.2018.07.029_bib0185","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/AAC.39.12.2759","article-title":"Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans","volume":"39","author":"Soul-Lawton","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.annder.2018.07.029_bib0190","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archinte.1996.00440140169018","article-title":"A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group","volume":"156","author":"Spruance","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.annder.2018.07.029_bib0195","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ajog.2005.11.051","article-title":"Valacyclovir therapy to reduce recurrent genital herpes in pregnant women","volume":"194","author":"Andrews","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annder.2018.07.029_bib0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archderm.134.2.185","article-title":"A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group","volume":"134","author":"Tyring","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2018.07.029_bib0205","first-page":"110","article-title":"Valaciclovir versus aciclovir in patien-initiated treatment of recurrent genital herpes: a randomised, double-blind clinical trial. International Valaciclovir HSV Study Group","volume":"73","author":"Bodsworth","year":"1997","journal-title":"Genitourin Med"},{"key":"10.1016\/j.annder.2018.07.029_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-006-0234-z","article-title":"Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpes","volume":"275","author":"Tyring","year":"2007","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.annder.2018.07.029_bib0215","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/339325","article-title":"Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2\u00a0infection","volume":"34","author":"Wald","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annder.2018.07.029_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/150.1.1","article-title":"A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo","volume":"150","author":"Luby","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annder.2018.07.029_bib0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJM198206033062201","article-title":"A trial of topical acyclovir in genital herpes simplex virus infections","volume":"306","author":"Corey","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2018.07.029_bib0230","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0002-9343(82)90117-6","article-title":"Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections","volume":"73","author":"Corey","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.annder.2018.07.029_bib0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0029-7844(95)00357-6","article-title":"Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes","volume":"87","author":"Scott","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annder.2018.07.029_bib0240","first-page":"CD004946","article-title":"Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection","volume":"1","author":"Hollier","year":"2008","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.annder.2018.07.029_bib0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0301-2115(00)00406-1","article-title":"Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding","volume":"96","author":"Braig","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annder.2018.07.029_bib0250","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mob.2003.185","article-title":"A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery","volume":"188","author":"Watts","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annder.2018.07.029_bib0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-0528.1998.tb10086.x","article-title":"A randomised placebo-controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.annder.2018.07.029_bib0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.AOG.0000219749.96274.15","article-title":"Valacyclovir prophylaxis to prevent recurrent herpes at delivery","volume":"108","author":"Sheffield","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annder.2018.07.029_bib0265","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1155\/S1064744902000054","article-title":"Acyclovir suppression to prevent recurrent genital herpes at delivery","volume":"10","author":"Scott","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.annder.2018.07.029_bib0270","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jgyn.2012.04.014","article-title":"Trends in perinatal health in France from 1995\u00a0to 2010. Results from the French National Perinatal Surveys","volume":"41","author":"Blondel","year":"2012","journal-title":"J Gynecol Obstet Biol Reprod"},{"issue":"6","key":"10.1016\/j.annder.2018.07.029_bib0295","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1701-2163(16)32868-7","article-title":"Guidelines for the management of herpes simplex virus in pregnancy","volume":"30","author":"Money","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.annder.2018.07.029_bib0280","unstructured":"RCOG. Management of genital herpes in pregnancy. https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/guidelines\/genital-herpes\/."},{"key":"10.1016\/j.annder.2018.07.029_bib0285","first-page":"1489","article-title":"Clinical management guidelines for obstetrician-gynecologists. No. 82\u00a0June 2007. Management of herpes in pregnancy","volume":"109","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annder.2018.07.029_bib0145","unstructured":"Version control and change history Clinical Guideline Herpes Simplex Virus (HSV) Infection in Pregnancy. http:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/91b9ab004ee4825781368dd150ce4f37\/genital+herpes+simplex+infection+in+pregnancy_27042016.pdf"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818307178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963818307178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:06:43Z","timestamp":1758971203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963818307178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0151963818307178"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.029","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommandations diagnostiques et th\u00e9rapeutiques pour les maladies sexuellement transmissibles\u00a0: herp\u00e8s g\u00e9nital au cours de la grossesse","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2018.07.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}